中国医学创新
中國醫學創新
중국의학창신
Medical Innovation of China
2015年
28期
56-58,59
,共4页
吴红%殷育茜%赵春宁
吳紅%慇育茜%趙春寧
오홍%은육천%조춘저
复方托吡卡胺%近视%儿童
複方託吡卡胺%近視%兒童
복방탁필잡알%근시%인동
Compound tropicamide%Myopia%Children
目的:探讨复方托吡卡胺滴眼液在近视儿童屈光检查中的应用效果。方法:将56例(112只眼)7~17岁近视患者分为7~12岁组和13~17岁组,在散瞳前后,由有经验的验光师对患者进行电脑验光和检影验光,应用SPSS 17.0统计软件比较每组用药前后等效球镜(SE)值的变化。结果:每组散瞳前后SE值比较差异均无统计学意义(P>0.05)。结论:复方托吡卡胺滴眼液是一种睫状肌麻痹剂,但对不同年龄的儿童睫状肌麻痹作用效果有限,且散瞳前后屈光度无明显变化。
目的:探討複方託吡卡胺滴眼液在近視兒童屈光檢查中的應用效果。方法:將56例(112隻眼)7~17歲近視患者分為7~12歲組和13~17歲組,在散瞳前後,由有經驗的驗光師對患者進行電腦驗光和檢影驗光,應用SPSS 17.0統計軟件比較每組用藥前後等效毬鏡(SE)值的變化。結果:每組散瞳前後SE值比較差異均無統計學意義(P>0.05)。結論:複方託吡卡胺滴眼液是一種睫狀肌痳痺劑,但對不同年齡的兒童睫狀肌痳痺作用效果有限,且散瞳前後屈光度無明顯變化。
목적:탐토복방탁필잡알적안액재근시인동굴광검사중적응용효과。방법:장56례(112지안)7~17세근시환자분위7~12세조화13~17세조,재산동전후,유유경험적험광사대환자진행전뇌험광화검영험광,응용SPSS 17.0통계연건비교매조용약전후등효구경(SE)치적변화。결과:매조산동전후SE치비교차이균무통계학의의(P>0.05)。결론:복방탁필잡알적안액시일충첩상기마비제,단대불동년령적인동첩상기마비작용효과유한,차산동전후굴광도무명현변화。
Objective:To study the effect of the applying of compound tropicamide eye drops in refractive inspection of children with myopia.Method:56 cases(112 eyes)myopia children aged from 7 to 17 years were grouped as group 7-12 years and 13-18 years.The refractive capacity of the eye was examined with a computer and a retinoscopy by skilled optometrist before and after mydriasis. The differences of the values of spherical equivalence(SE)before and after mydriasis were analyzed with SPSS 17.0 in every group.Result:There were no significant differences in the values of SE before and after mydriasis in each group(P>0.05).Conclusion:Compound tropicamide eye drops is a cycloplegic agent. But its effects are limited for children with different age.